HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterogeneity of cell surface receptors and mitogen reactivity of individual spontaneous AKR lymphomas.

Abstract
Eight spontaneous thymic lymphomas from AKR mice were characterized individually in vitro for cell surface receptors and mitogen reactivity. One of the thymic lymphomas, designated 105, displayed receptors for the Fc region of immunoglobulin and for complement on a portion of the Thy-1-positive lymphoid blasts. The other T cell lymphomas did not display either receptor, and none expressed cell surface immunoglobulin. This was in contrast to the distinct behavior of each lymphoma in culture in both spontaneous and mitogen-stimulated tritiated thymidine [3H]-dThd uptake. After 48 h of culture, spontaneous [3H]-dThd uptake of the individual lymphomas ranged from 137 +/- 27 cpm to 100,442 +/- 13,422 cpm. Four of the spontaneous lymphomas did not respond to T cell mitogens by increased [3H]-dThd uptake. One lymphoma responded to the T cell mitogen concanavalin A only, whereas two lymphomas were stimulated by both phytohemagglutinin and concanavalin A. None of the lymphomas were stimulated by the B cell mitogen, lipopolysaccharide.
AuthorsL J Nell, E R Richie
JournalExperimental hematology (Exp Hematol) Vol. 9 Issue 6 Pg. 611-8 (Jul 1981) ISSN: 0301-472X [Print] Netherlands
PMID6973483 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Phytohemagglutinins
  • Receptors, Antigen, B-Cell
  • Receptors, Complement
  • Receptors, Immunologic
Topics
  • Animals
  • Cells, Cultured
  • Lymphocyte Activation
  • Lymphoma (immunology)
  • Mice
  • Mice, Inbred AKR (immunology)
  • Phytohemagglutinins (pharmacology)
  • Receptors, Antigen, B-Cell
  • Receptors, Complement
  • Receptors, Immunologic
  • T-Lymphocytes (immunology)
  • Thymus Neoplasms (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: